Recruiting
Phase 1
Phase 2

Magnetic Therapy & Seawater

Sponsor:

American Society Of Thermalism And Climatology Inc

Code:

NCT02300818

Conditions

Primary Open Angle Glaucoma

Hypertension Ocular

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Pulsed Electromagnetic Field Therapy

Seawater eyedrops

Study Details

Brief summary:

Glaucoma is among the leading causes for blindness in the western world. Elevated intraocular pressure (IOP) has been identified as the most important risk factor. However, some patients progress despite adequate IOP lowering while some subjects with elevated IOP never develop glaucoma. Other patients develop glaucoma although IOP measurements were always in the normal range. Therefore, other factors must be involved. In the last years, studies using MRI have been performed and evidence has accumulated that also changes in retrobulbar structures are present, in particular in the lateral geniculate nucleus and the visual cortex. However, these studies were limited by the low spatial resolution of the MRI instruments used.

Conditions

Primary Open Angle Glaucoma

Hypertension Ocular

Study ID

NCT02300818

Start date

Nov, 2014

Status verified date

Jun, 2015

Completion date

Dec, 2016

Anticipated

Primary completion date

Apr, 2016

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

Patient is aged 18 years or older, with glaucoma include poorly controlled open angle glaucoma (Pigmentary \& Exfoliative Glaucoma) Patient is willing to participate in the 3-month study and to adhere to the follow-up schedule.

Patient is willing to review and sign a consent form.

Exclusion Criteria:

Prior glaucoma surgery other than laser trabeculoplasty or peripheral iridotomy.

Patient has mental impairment such that he/she could not understand the protocol or is not in a position to provide written informed consent.

Patient is pregnant. Patient might require other ocular surgery within the 6-month follow-up period. Having concurrent treatment with systemic steroids. Patient is under 18 years old -

Study Design

Enrollment

100 participants

Anticipated

Allocation

Randomized

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

active comparator: Pulsed Electromagnetic Field Therapy

Pulsed Electromagnetic Field Therapy widely termed as (PEMF) is a reparative technique used for treatment of eye therapy has proved to be a beneficial treatment for those suffering from glaucoma. This therapy helps in increased blood flow and show positive results on latent, initial and advanced glaucoma with ten sessions of seven minutes' each.

PEMF has also proved to be beneficial in vision acuity of patients with low vision. In 50 per cent of the cases, values improved. Patients with vision acuity of 0.2 diopters showed improvement from 46 before treatment to 75 after treatment.

Different studies on varied diseases have proved that Pulsed Electromagnetic Field Therapy (PEMF) treatment is a safe, non-invasive and effective option for curing ocular conditions.

active comparator: Seawater eyedrops

instantly soothes and clears the eye irritation caused by pollution, pollen, smoke, etc. It is a very practical system for eye daily hygiene · enables efficient therapeutic help in basic eye conditions such as: · · internal and external stye blepharitis and keratoconjunctivitis · · Conjuntiviti Episcleritis and scleritis

Interventions

Pulsed Electromagnetic Field Therapy

Pulsed Electromagnetic Field Therapy widely termed as (PEMF) is a reparative technique used for treatment of eye therapy has proved to be a beneficial treatment for those suffering from glaucoma. This therapy helps in increased blood flow and show positive results on latent, initial and advanced glaucoma with ten sessions of seven minutes' each.

Seawater eyedrops

Eye-drops daily 1 time a day for 12 weeks

Primary outcome measure

  • Intro-ocular pression after magnetic field exposition [ Time Frame: 12 weeks ]

Central Contacts and Locations

Central contacts

Garis Silega

9739006397drsilega@aol.com

Locations

Gaviota Clinic

Recruiting

Newark, New Jersey, United States, 07105

Contacts

Garis Silega, Dr

862-229-4766drsilega@aol.com

Principal Investigator:

Garis Silega, Dr

More Information

Sponsor

American Society Of Thermalism And Climatology Inc

Last update posted

Jun 23, 2015

Last verified

Jun, 2015

Keywords

  • Hipertension ocular, Glaucoma, Magnetotherapy, seawater

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by American Society Of Thermalism And Climatology Inc on 2015-06-23.